SLC5A2 and diabetes mellitus: Finally, another study measured the effect of acute administration of an SGLT1 and 2 inhibitor (O'Neill et al., 2015), which has little relevance on the impact of long term therapy with specific SGLT‐2 inhibition in animals or patients with established diabetes.